Research ArticleCANCER

Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms

See allHide authors and affiliations

Science Advances  07 Feb 2020:
Vol. 6, no. 6, eaav7416
DOI: 10.1126/sciadv.aav7416
PDF Container

Stay Connected to Science Advances

Navigate This Article